Nevertheless, the pre-treatment with sumatriptan (but not ketorolac) is able to prevent PACAP38-induced migraine attacks without affecting PACAP38-induced arterial dilation, while post-treatment with ketorolac, but not sumatriptan, attenuated PACAP38-induced headache [35]. This evidence concerns the gene ADCYAP1 and migraine disorder.